Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Engelman

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Plos Medicine|November 10, 2021
Community control strategies for scabies: A cluster randomised noninferiority trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
Plos Neglected Tropical Diseases|May 23, 2022
Using quantitative PCR to identify opportunities to strengthen soil-transmitted helminth control in Solomon Islands: A cross-sectional epidemiological surveyBrandon Le, Naomi Clarke, Sze Fui Hii, et al.
Plos Neglected Tropical Diseases|December 9, 2020
Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019Li Jun Thean, Adam Jenney, Daniel Engelman, et al.
BMC Public Health|November 11, 2021
Estimation of scabies prevalence using simplified criteria and mapping procedures in three Pacific and southeast Asian countriesShu Ki Tsoi, Susanna J Lake, Li Jun Thean, et al.
BMJ Open|September 2, 2020
Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)Susanna J Lake, Sophie L Phelan, Daniel Engelman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigoLi Jun Thean, Adam Jenney, Daniel Engelman, et al.
International Journal of Cardiology|December 23, 2023
Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxisBruno R Nascimento, Maria Carmo P Nunes, Jose Luiz P da Silva, et al.
The Lancet. Global Health|May 18, 2023
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessmentBrandon Le, Merita Antonia Armindo Monteiro, Salvador Amaral, et al.
The Lancet Regional Health. Western Pacific|March 29, 2022
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020Li Jun Thean, Lucia Romani, Daniel Engelman, et al.
Plos Neglected Tropical Diseases|March 17, 2023
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trialSusanna J Lake, Daniel Engelman, Julie Zinihite, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Plos Medicine|November 10, 2021
Community control strategies for scabies: A cluster randomised noninferiority trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
Plos Neglected Tropical Diseases|May 23, 2022
Using quantitative PCR to identify opportunities to strengthen soil-transmitted helminth control in Solomon Islands: A cross-sectional epidemiological surveyBrandon Le, Naomi Clarke, Sze Fui Hii, et al.
Plos Neglected Tropical Diseases|December 9, 2020
Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019Li Jun Thean, Adam Jenney, Daniel Engelman, et al.
BMC Public Health|November 11, 2021
Estimation of scabies prevalence using simplified criteria and mapping procedures in three Pacific and southeast Asian countriesShu Ki Tsoi, Susanna J Lake, Li Jun Thean, et al.
BMJ Open|September 2, 2020
Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)Susanna J Lake, Sophie L Phelan, Daniel Engelman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigoLi Jun Thean, Adam Jenney, Daniel Engelman, et al.
International Journal of Cardiology|December 23, 2023
Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxisBruno R Nascimento, Maria Carmo P Nunes, Jose Luiz P da Silva, et al.
The Lancet. Global Health|May 18, 2023
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessmentBrandon Le, Merita Antonia Armindo Monteiro, Salvador Amaral, et al.
The Lancet Regional Health. Western Pacific|March 29, 2022
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020Li Jun Thean, Lucia Romani, Daniel Engelman, et al.
Plos Neglected Tropical Diseases|March 17, 2023
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trialSusanna J Lake, Daniel Engelman, Julie Zinihite, et al.
Pageof 10